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Abstract
Alzheimer's disease (AD) is the most common cause of dementia in older adults. By the time an 
individual has been diagnosed with AD, it may be too late for potential disease modifying therapy 
to strongly influence outcome. Therefore, it is critical to develop better diagnostic tools that can 
recognize AD at early symptomatic and especially pre-symptomatic stages. Mild cognitive 
impairment (MCI), introduced to describe a prodromal stage of AD, is presently classified into 
early and late stages (E-MCI, L-MCI) based on severity. Using a graph-based semi-supervised 
learning (SSL) method to integrate multimodal brain imaging data and select valid imaging-based 
predictors for optimizing prediction accuracy, we developed a model to differentiate E-MCI from 
healthy controls (HC) for early detection of AD. Multimodal brain imaging scans (MRI and PET) 
of 174 E-MCI and 98 HC participants from the Alzheimer's Disease Neuroimaging Initiative 
(ADNI) cohort were used in this analysis. Mean targeted region-of-interest (ROI) values extracted 
from structural MRI (voxel-based morphometry (VBM) and FreeSurfer V5) and PET (FDG and 
Florbetapir) scans were used as features. Our results show that the graph-based SSL classifiers 
outperformed support vector machines for this task and the best performance was obtained with 
66.8% cross-validated AUC (area under the ROC curve) when FDG and FreeSurfer datasets were 
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integrated. Valid imaging-based phenotypes selected from our approach included ROI values 
extracted from temporal lobe, hippocampus, and amygdala. Employing a graph-based SSL 
approach with multimodal brain imaging data appears to have substantial potential for detecting E-
MCI for early detection of prodromal AD warranting further investigation.
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1 Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disease in older adults and at 
this time, despite incidence rates doubling every 5 years after the age of 65, there is no 
effective disease modifying treatment for AD to date [1]. AD is predicted to affect 14 
million Americans by the year 2050 (www.alz.org) and has become a national priority. The 
detection and diagnosis of AD at the earliest possible stage is of fundamental importance as 
early intervention could potentially delay progression to AD and achieve effective disease 
modification. One of main challenges is to identify and validate biomarkers of AD 
progression leading to an improved early diagnosis at early symptomatic and especially pre-
symptomatic stages. To this end, the concept of mild cognitive impairment (MCI) was 
introduced [2]. MCI can be classified into early and late stages (E-MCI, L-MCI) based on 
severity. MCI is thought to be a precursor to the development of early AD, and subjects with 
late amnestic MCI have a highly elevated probability of developing AD with a conversion 
rate of approximately 15% per year [3, 4].
New approaches to the search for specific biomarkers to detect MCI/AD compared to 
healthy controls (HC) have been developed, with neuroimaging (MRI and PET) and 
cerebrospinal fluid (CSF) biochemical markers showing particular promise [5, 6]. However, 
in most studies, only patients with L-MCI and AD have been assessed [7]. In order to 
identify better diagnostic tools that can recognize AD at early symptomatic and especially 
pre-symptomatic stages, we developed a graph-based semi-supervised learning model to 
differentiate E-MCI from HC for early detection of AD using multimodal brain imaging 
scans (MRI and PET) of participants from the ongoing Alzheimer's Disease Neuroimaging 
Initiative (ADNI).
The semi-supervised learning (SSL) which recently emerged in the machine learning 
domain, employs a strategy halfway between supervised and unsupervised learning schemes 
to improve classification performance [8-11]. In particular, the graph-based SSL takes 
advantage of computational efficiency and representational ease for the biomedical data. 
Because of the graph structures, it is easy to integrate different types of data for better 
explaining clinical outcomes [12]. The learning time of graph-based SSL is nearly linear 
with the number of graph edges while the accuracy remains comparable to the kernel-based 
methods that suffer from the relative disadvantage of a longer learning time [13, 14]. In 
addition, the interpretation of biological phenomena can be improved because of the graph 
structure [15-17], which naturally fits into the graph-based SSL.
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2 Materials and Methods
2.1 Data
Samples—The Alzheimer's Disease Neuroimaging Initiative initial phase (ADNI-1) was 
launched in 2003 to test whether serial magnetic resonance imaging (MRI), position 
emission tomography (PET), other biological markers, and clinical and neuro-psychological 
assessment could be combined to measure the progression of MCI and early AD. This multi-
site longitudinal study was intended to aid researchers and clinicians develop new treatments 
for MCI and early AD, monitor their effectiveness, and lessen the time and cost of clinical 
trials. The ADNI-1 has been extended to its subsequent phases (ADNI-GO and ADNI-2) for 
follow-up for existing participants and additional new enrollments. Inclusion and exclusion 
criteria, clinical and neuroimaging protocols, and other information about ADNI have been 
published previously and can be found at www.adni-info.org [18-20]. Demographic 
information, raw scan data, APOE and GWAS genotypes, neuropsychological test scores, 
and diagnostic information are available from the ADNI data repository (http://
www.loni.ucla.edu/ADNI/). Individuals included in this study were 174 E-MCI (early MCI) 
and 98 HC (healthy older adults) participants in ADNI-GO or ADNI-2.
Image processing—All available baseline 3T structural brain MRI scans were 
downloaded from the ADNI database. As detailed in previous studies [18, 19], two widely 
employed automated MRI analysis techniques were independently used to process MRI 
scans: whole-brain voxel-based morphometry (VBM) implemented in the Statistical 
Parametric Mapping 8 (SPM8) software to extract mean grey matter (GM) density for target 
regions of interest (ROIs) and FreeSurfer version 5.1 to extract mean cortical thickness and 
volumetric measure for target ROIs. Pre-processed Florbetapir (also known as AV-45 and 
Amyloid) PET scans to assess brain amyloid β burden were downloaded from the ADNI 
database. For each scan, mean regional SUVR (standardized uptake value ratio) values were 
extracted for target ROIs using MarsBaR in SPM8, as detailed in previous study [7, 18]. 
FDG-PET was used to measure the brain's rate of glucose metabolism with the tracer [18F] 
Fluorodeoxyglucose. FDG-PET ROI data was downloaded from the ADNI database. All 
MRI ROI values were adjusted for the baseline age, gender, education, and intracranial 
volume (ICV) using a regression model, prior to analyses. All the ROI values of Florbetapir 
and FDG PET were adjusted for the baseline age, gender, and education.
2.2 Classification of Early Mild Cognitive Impairment (E-MCI)
The semi-supervised learning uses both labeled and unlabeled data to improve on the 
performance of supervised learning. There are several types of SSL algorithms, and the 
graph-based SSL was used in our study. If two patients’ samples were more closely related 
to others, the algorithm assumed that the diagnosis of E-MCI from those two patients is 
more likely to be similar. Thus, the classification of E-MCI can be enhanced by considering 
similarities between patient samples. A natural method of analyzing relationships between 
entities is a graph, where nodes represent participants and edges show their possible 
relations. Figure 1 represents an example graph, which was conducted using the brain 
imaging data. An annotated participant is labeled either by ‘-1’ or ‘1’, indicating the two 
possible clinical outcomes, either ‘healthy older adult’ or ‘E-MCI’. In order to predict the 
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label of the unannotated patient ‘?’, the edges connected from/to the patient play an 
important role in influencing propagation of the relation between the patient and its 
neighbors. This idea can be easily formulated using a graph-based semi-supervised learning 
[8]. Edges represent relations, more specifically similarities between participants that may 
be extracted from different brain imaging data. Different brain imaging data produce 
different graphs. Thus, the classification of E-MCI can be benefit by integrating diverse 
graphs from multimodal brain imaging data, i.e., incomplete information and noise. 
Technically, the data-setup of our experiment for the binary classification can be rephrased 
as  where xn ∈ Rd (d is the number of features and N is the number of 
participants) and yn ∈ {−1, 1}.
Graph-based semi-supervised learning—In the graph-based SSL [8], a participant xi 
(i = 1,...,n) is represented as a node i in a graph, and the relationship between participants is 
represented by an edge. The edge strength from each node j to other node i is encoded in 
element wij of a n × n symmetric weight matrix W. A Gaussian function of Euclidean 
distance between participants, with length scale hyperparameter σ, is used to specify 
connection strength:
(1)
Nodes i and j are connected by an edge if i is in j's k-nearest-neighborhood or vice versa. 
Thus, nearby participants in Euclidean spaces are assigned large edge weights.
The labeled nodes have labels yl ∈ {-1, 1}, while the unlabeled nodes have zeros yu = 0. The 
graph-based SSL will output an n-dimensional real-valued vector 
, which can be thresholded to make label 
predictions on fl=f1,...,fn after learning. It is assumed that fi should be close to the given label 
yi in labeled nodes (loss condition), and overall, fi should not be too different from the fi of 
adjacent nodes (smoothness condition). One can obtain f by minimizing the following 
quadratic functional [8, 9, 11]:
(2)
where y=(y1,...,yl, 0,...0)T, and the matrix L, called the graph Laplacian matrix [21], is 
defined as L = D – W where D = diag(di), di= Σjwij. The parameter μ trades off loss versus 
smoothness. The solution of this problem is obtained as
(3)
where I is the identity matrix.
Kim et al. Page 4
Multimodal Brain Image Anal (2013). Author manuscript; available in PMC 2014 November 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
2.3 Integration of Multi-Modal Brain Imaging Dataset
In order to combine the graphs from multimodal brain imaging data, four graphs can be 
integrated from finding optimum combination coefficients. Information from each graph is 
regarded as partially independent from and partly complementary to others. Reliability may 
be enhanced by integrating all available data sources using the graph-based SSL, which has 
been applied to the extended problem of protein function prediction [22] and clinical 
outcome prediction using multi-levels of genomic data [12]. Based on the method, the 
integration of multiple graphs is used to find an optimum value of the linear combination 
coefficient for the individual graphs (Fig. 2). This corresponds to finding the combination 
coefficients α for the individual Laplacians of the following mathematical formulation:
(4)
, where K is the number of graphs and Lk is the corresponding graph-Laplacian of graph Gk. 
Similar to the output prediction for single graphs, the solution is obtained by
(5)
3 Results
3.1 Experiment Setting
The receiver operating characteristic (ROC) curve plots sensitivity (true positive rate) as a 
function of 1-specificity (false positive rate) for a binary classifier system as its 
discrimination threshold is varied [23]. An ROC score of 0.5 corresponds to random 
prediction, and an ROC score of 1.0 implies that the model succeeded in putting all of the 
positive examples before all of the negatives. For each dataset, we calculated area under the 
curve (AUC) of ROC as a performance measure. In order to avoid the overfitting, five-fold 
cross-validation was conducted. Since some of the brain imaging dataset is high dimensional 
and noisy, and contains many redundant features, which may incur computational difficulty 
and low accuracy, a Student t-test based feature selection method was used [24]. Even 
though there are many feature selection techniques such as filter, wrapper, and embedded 
method [25], a simple univariate feature selection method was used in order to emphasize 
not the effect of feature selection but the effect of integration of multimodal brain imaging 
data. The values of SSL model parameters, k from Equation (1) and μ from Equation (3), 
were determined by the results of search over k ∈ {3, 4, 5, 6, 7, 8, 9, 10, 20, 30} and μ ∈ 
{0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 10, 100, 1000}. The 
optimized combination of model parameters was selected when the greatest AUC was 
obtained.
3.2 Experiment Results
With multimodal brain imaging data, we provide empirical comparison results about which 
type of brain imaging data is more informative to a given classification problem for 
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diagnosis of E-MCI. Figure 3 shows the AUC performance on the classification of E-MCI. 
The averages of five-fold AUCs from Florbetapir, FDG, FreeSurfer, and VBM are shown in 
the figure. Among four types of brain imaging dataset, the performance of FreeSurfer 
dataset showed the best single modality performance with 0.6576 AUC. In Figure 3, AUC 
increases in the order of the following dataset, FreeSurfer > VBM > FDG > Florbetapir.
3.3 Integration Effects
Since different brain imaging data contain partly independent and partly complementary 
information content, we integrated across multi-modal brain image datasets for better 
prediction of E-MCI. We found that multivariate integration across different brain imaging 
modalities increased the prediction performance for patients with EMCI. Figure 4 shows the 
results of the integration with all combination of different types of brain imaging dataset. 
The model combining Florbetapir and VBM (0.6322 AUC) outperformed the model with 
VBM only (0.609 AUC). In addition, the integration with FDG and FreeSurfer showed the 
best performance among all combination of four different types of brain imaging dataset 
with 0.6681 AUC. However, the integration with all four types of brain image data included 
did not show the best performance.
3.4 Comparison with SVM
The performance from graph-based SSL classifiers was compared with Support Vector 
Machine (SVM) performance. SVM involves finding an optimal decision boundary, i.e., 
maximizing the margin by finding the largest achievable distance among the separating 
hyperplane and the data points on either side. If the data points are separated by a non-linear 
hyperplane because of some intrinsic property of the problem, it is more appropriate to map 
the input feature space to a high-dimensional feature space where the data points are 
separated by a linear hyperplane. This mapping process is conducted by kernel functions. 
Among kernel functions, the Radial Basis Function (RBF) kernel was used with a wide 
range of sigma, from 10−6 to 1, in order to select the best model. In order to fairly compare 
the performance, we used the same set of features, which was used in the graph-based SSL. 
The models from the graph-based SSL outperformed the models from SVM except for 
Florbetapir data (Table 1). The Wilcoxon signed-rank test was used to assess the 
significance level of difference in performance between the results of the graph-based SSL 
and SVM [26]. The model with FreeSurfer dataset from the graph-based SSL showed 
significantly better than the one from SVM.
4 Discussions and Conclusions
Using automatic whole-brain ROI analysis techniques and a graph-based semi-supervised 
learning (SSL) method, we developed a classification model to differentiate E-MCI from 
HC for early detection of AD. In this study, we used MRI (FreeSurfer and VBM) and PET 
(Florbetapir and FDG) scans from 174 E-MCI and 98 HC in the ADNI cohort. The graph-
based SSL technique was used to integrate multi-modal brain imaging data and select 
imaging-based phenotypes for optimizing E-MCI prediction accuracy. The data integration 
framework for multimodal brain imaging data has scalability to easily extend to additional 
types of brain imaging data. In addition, it preserves type-specific properties from the brain 
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imaging data since the matrices from different types of brain imaging data were not simply 
merged but combined after conversion into a graph for the integration (Fig. 2).
Our results showed that 1) the graph-based SSL classifiers outperformed support vector 
machines (SVM) for this task; 2), we obtained the best results when using ROI values 
extracted by FreeSurfer from structural MRI scans; (3) the overall best performance was 
obtained with 66.8% cross-validated AUC when FDG PET and FreeSurfer data were 
combined; (4) the integration with all four types of brain image data included did not show 
the best performance; and (5) selected imaging-based phenotypes included ROI values 
extracted from temporal lobe, hippocampus, and amygdala. It has been showed that regional 
brain atrophy occurs initially and most severely in the entorhinal cortex and hippocampus 
before spreading throughout the neocortex [27]. These findings suggest that the predictive 
model may be combined with various data sources from different types of brain imaging 
data. Integration of independent or complementary information content may improve the 
chances of successful early diagnosis of AD. The graph-based SSL approach with 
multimodal brain imaging data has substantial potential for enhanced early detection of AD.
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Fig. 1. 
Graph representation of brain imaging data between participants. Nodes represent 
participants and edges depict relations between samples. An annotated sample is labeled 
either by −1 or +1. In this example, the negative labels indicate samples from ‘healthy older 
adults’. On the contrary, the positive labels indicate the samples from ‘E-MCI’. The 
diagnosis of the unannotated sample marked as ‘?’ is predicted by employing the graph-
based semi-supervised learning.
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Fig. 2. 
Integration scheme of four different types of brain imaging data. Each brain imaging data 
can be converted into a graph, and then multiple graphs can be combined through finding 
the optimal value of the combination coefficient.
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Fig. 3. 
Performance comparison among four types of brain imaging dataset. The y axis represents 
the average AUC and the x axis shows the date type.
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Fig. 4. 
Integration of multimodal brain imaging data. The y axis represents the average AUC and 
the x axis shows the combination of brain imaging datasets.
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Table 1
Comparison between the graph-based SSL and SVM. P-values were calculated using a Wilcoxon signed-rank 
test between performance (AUC) of the graph-based SSL and SVM.
Data type Graph-based SSL SVM P-value
Florbetapir 0.5789 (± 0.0732) 0.5825 (± 0.0372) 1.0000
FDG 0.5873 (± 0.0587) 0.5664 (± 0.0643) 0.8413
FreeSurfer 0.6576 (± 0.0905) 0.5163 (± 0.0552) 0.0159
VBM 0.609 (± 0.1059) 0.5709 (± 0.0916) 0.5476
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